The United States Food and Drug Administration announced a sweeping policy reversal Monday that could transform how millions of American women access treatment for menopause symptoms, eliminating the most severe warnings that have shadowed hormone therapies for more than two decades. The decision marks a significant departure from the regulatory stance that emerged after a […]

The postFDA drops black box warnings on menopause therapiesappeared first onRolling Out.